Study to Evaluate the Impact of the Recovery Pathway on Postoperative Leght of Stay in Coronary Artery Bypass Surgery
Recruiting
N/AInterventional Study
Enhanced Recovery After SurgeryQuality Improvement
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Sex
Any
Study type
Interventional
Purpose
Supportive Care
Participants needed
128 (estimated)
Sponsor
University of Sao Paulo General Hospital · Other
Who this trial is looking for
This trial is looking for adult patients who will have heart bypass surgery. Participants will either follow a quick recovery plan or the usual care plan after their surgery.
Are You a Good Fit for This Trial?
You may be able to join if
I am an adult over 18 years old
I will have isolated coronary artery bypass surgery
I can provide signed consent to join the trial
You may not be able to join if
I am having emergency surgery
I have severe heart dysfunction
I have kidney problems
I have atrial fibrillation or need blood thinners
I have moderate to severe anemia
I have a high STS risk score over 4%
I or my family do not agree with the study
I cannot sign the informed consent form
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
This randomized and prospective trial aims to evaluate the implementation of a rapid recovery protocol for coronary artery bypass grafting (CABG) in a hospital serving patients from the Brazilian Unified Health System (Sistema Único de Saúde - SUS). The study will compare outcomes between two groups: patients receiving care under the rapid recovery protocol and those following the standard institu…
This randomized and prospective trial aims to evaluate the implementation of a rapid recovery protocol for coronary artery bypass grafting (CABG) in a hospital serving patients from the Brazilian Unified Health System (Sistema Único de Saúde - SUS). The study will compare outcomes between two groups: patients receiving care under the rapid recovery protocol and those following the standard institutional care.
Primary Objective:
Compare postoperative hospital stay between the rapid recovery group and the usual care group.
Secondary Objectives:
Assess morbidity and mortality between both groups.
Evaluate patient satisfaction using validated tools.
Analyze incremental costs associated with both approaches.
Assess healthcare teams' learning progression regarding the protocol (Kirkpatrick method).
Evaluate adherence to rapid recovery protocol metrics by healthcare teams.
Measure changes in patient safety culture among healthcare professionals.
Hypothesis:
The null hypothesis assumes no difference in hospital stay between the two groups. The alternative hypothesis suggests that the rapid recovery protocol will reduce hospital stay compared to the standard care. Previous findings from Mejia et al. (2022) indicated a 40% reduction in postoperative hospital stay (from 13 to 7.8 days) for cardiac surgery patients under a rapid recovery protocol at the Heart Institute (InCor HCFMUSP).
This trial will provide critical insights into the applicability of enhanced recovery after surgery (ERAS) principles in cardiac surgery within the context of public healthcare, aiming to improve outcomes and optimize resource use.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* Adult patients (\>18 years old)
* Undergoing isolated coronary artery bypass grafting (CABG) with elective or urgent status
* Signed informed consent form (ICF)
Exclusion Criteria:
* Emergency patients
* Severe ventricular dysfunction (ejection fraction \<30%)
* Renal impair…
Inclusion Criteria:
* Adult patients (\>18 years old)
* Undergoing isolated coronary artery bypass grafting (CABG) with elective or urgent status
* Signed informed consent form (ICF)
Exclusion Criteria:
* Emergency patients
* Severe ventricular dysfunction (ejection fraction \<30%)
* Renal impairment (creatinine clearance \<30 mL/min)
* Atrial fibrillation or need for oral anticoagulation
* Moderate-to-severe anemia (hematocrit \<32%)
* STS risk score \>4%
* Patient and/or family disagreement with the protocol
* Failure to sign the informed consent form
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.